Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |